, W. C., , Z. C., , C. L., , X. L., , Y. C., & , J. Z. (2024). Honokiol Mitigates Metabolic-Associated Fatty Liver Disease by Regulating Nrf2 and RIPK3 Signaling Pathways. Turkish Journal of Gastroenterology 1, 35(7), 15–18. https://doi.org/10.5152/tjg.2024.23470